“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”
Related posts:
U.S. Customs Fines Woman $500 For Saving Free Delta Airlines Snack
Suit Goes To Bat For Future Taxpayers [1986]
JPMorgan Joins Goldman in Designing Derivatives for a New Generation
Kyle Bass Tells 'Nominal' Stock Market Cheerleaders: Remember Zimbabwe
Bitcoin: Greece's new euro workaround?
IRS Still Stealing Cash From Immigrant Business Owners
White House faces high bar on Syria after Bush Administration’s Iraq lies
Bitcoin a perfect currency, says Chinese investor
More Fast and Furious guns surface at crimes in Mexico
Woman Sues Pantego Police Over Burst Breast Implant
How An African 'Princess' Banked $3 Billion In A Country Living On $2 A Day
Court could declare Obamacare subsidies illegal in 34 states
Trump announces trade war with Canada, retroactive 20% tax on lumber
IRS Data Web Snares Mostly Low- and Middle-Income Taxpayers
Apple becomes most valuable company in history